Trial · NCT02500797
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Initial Cohort - Arm I (Nivolumab) | 43 | |
| Overall Study | STARTED | Initial Cohort - Arm II (Nivolumab, Ipilimumab) | 42 | |
| Overall Study | STARTED | Expansion LPS Cohort - Arm I (Nivolumab) | 15 | |
| Overall Study | STARTED | Expansion LPS Cohort - Arm II (Nivolumab, Ipilimumab) | 14 | |
| Overall Study | STARTED | Expansion UPS/MFH Cohort - Arm I (Nivolumab) | 14 | |
| Overall Study | STARTED | Expansion UPS/MFH Cohort - Arm II (Nivolumab, Ipilimumab) | 15 | |
| Overall Study | STARTED | Expansion GIST Cohort - Arm I (Nivolumab) | 10 | |
| Overall Study | STARTED | Expansion GIST Cohort - Arm II (Nivolumab, Ipilimumab) | 11 | |
| Overall Study | Arm I Crossover | Initial Cohort - Arm I (Nivolumab) | 4 | |
| Overall Study | Arm I Crossover | Initial Cohort - Arm II (Nivolumab, Ipilimumab) | 0 | |
| Overall Study | Arm I Crossover | Expansion LPS Cohort - Arm I (Nivolumab) | 6 | |
| Overall Study | Arm I Crossover | Expansion LPS Cohort - Arm II (Nivolumab, Ipilimumab) | 0 | |
| Overall Study | Arm I Crossover | Expansion UPS/MFH Cohort - Arm I (Nivolumab) | 1 | |
| Overall Study | Arm I Crossover | Expansion UPS/MFH Cohort - Arm II (Nivolumab, Ipilimumab) | 0 | |
| Overall Study | Arm I Crossover | Expansion GIST Cohort - Arm I (Nivolumab) | 2 | |
| Overall Study | Arm I Crossover | Expansion GIST Cohort - Arm II (Nivolumab, Ipilimumab) | 0 | |
| Overall Study | COMPLETED | Initial Cohort - Arm I (Nivolumab) | 42 | |
| Overall Study | COMPLETED | Initial Cohort - Arm II (Nivolumab, Ipilimumab) | 42 | |
| Overall Study | COMPLETED | Expansion LPS Cohort - Arm I (Nivolumab) | 15 | |
| Overall Study | COMPLETED | Expansion LPS Cohort - Arm II (Nivolumab, Ipilimumab) | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02500797/flow